Mounjaro is more effective for weight loss than Ozempic—how does it work? And why does it cost so much?
A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia. The drug, tirzepatide, is sold under the brand name Mounjaro and affects feelings of hunger and fullness,
Weight loss injections: How do drugs like Wegovy and Mounjaro work?
Both Wegovy and Mounjaro are given as weekly injections via pre-filled pens that can be self-administered into the upper arm, thigh or stomach. They work as an appetite suppressant by mimicking a hormone called glucagon-like peptide-1 (GLP-1).
Tori Spelling’s Weight Loss of 40 lbs Using Mounjaro And Ozempic
Here are insights into Tori Spelling’s weight loss journey and how the actress toned herself down. From medications to diet and workouts, learn all she tried!
Weight-loss drugs could reduce risk of overdoses, new study says
A new study suggests that medications like Ozempic could help reduce the risk of overdose and alcohol intoxication in people with substance use disorders.
Ozempic and other weight loss drugs could help treat alcohol and drug addiction, study says
The case that Ozempic (NVO) and other GLP-1 medications could help people with substance use disorders is getting stronger.
The Case for Ozempic as a Addiction Treatment Keeps Getting Better
Research from earlier this week is the latest to suggest that semaglutide and other GLP-1 drugs can help treat people's addiction to both opioids and alcohol.
Weight Loss Drugs Like Ozempic, Wegovy May Help Fight Alcoholism and Opioid Addiction
A new study reveals that glucagon-like peptide-1 receptor agonists (GLP-1), which include weight loss and diabetes meds Ozempic, Wegovy, Mounjaro or Zepbound, may help users overcome alcoholism and opioid addiction.
Weight loss drugs may help lower overdoses, alcoholism: Study
Researchers analyzed 1.3 million health records and found Ozempic, Mounjaro could lower rates of drug and alcohol overdoses.
Why We May Soon Use Ozempic to Treat Addiction
Becker's Hospital Review12h
FDA retreats from declaring end to Mounjaro shortage
In a reversal, the FDA is reconsidering its decision to end the shortage status of tirzepatide, after a recent lawsuit and intense public pressure, The Washington Post reported Oct. 21.
Ozempic shows promise for alcohol and drug addiction, study finds
The weight-loss drugs are linked with reduced rates of excess drinking and opioid overdoses, suggesting they may tamp down ...
ConsumerAffairs5d
Compounding pharmacies can keep making Mounjaro and Zepbound copies
The U.S. Food and Drug Administration (FDA) is rethinking its decision to remove popular weight-loss and diabetes drugs from ...
Trade group sues FDA over ending Mounjaro/Zepbound shortage
A trade organization representing compounding pharmacies that make unbranded versions of the weight loss drugs Mounjaro and ...
Becker's Hospital Review7d
FDA to reconsider decision barring sale of compounded Mounjaro: 5 things to know
The reconsideration follows an Oct. 11 lawsuit that prompted U.S. District Judge Mark Pittman to temporarily halt legal proceedings to give the FDA time to reassess its ruling.
Wired13d
A Major GLP-1 Drug Shortage Is Over. Some Patients Aren’t Celebrating
It has been a long time coming: The active ingredient in the weight-loss drug Zepbound and diabetes medication Mounjaro has experienced runaway popularity, along with other GLP-1 meds like Ozempic.
FDA shakes up weight loss market as Mounjaro shortage ends
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound were no longer ...
Mounjaro Set for NHS Approval as Weight Loss Treatment
The weight loss jab Mounjaro will soon be made available to nearly a quarter of a million NHS patients, according to ...
Managed Healthcare Executive10h
The Link between GLP-1 Drugs and Diabetic Retinopathy is Not So Clear | AAO 2024
Clinical and other trials for GLP-1 therapies have found an association between these drugs and diabetic retinopathy ...